SLC7A7 and breast carcinoma: Interestingly, one cohort (GSE19615) including 115 samples showed that high SLC7A7 expression was associated with a better prognosis in breast cancer (distant metastasis-free survival [DMFS]; HR = 0.19, 95% CI 0.06–0.68, P = 0.0103).